| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 36% | 9/25 |
| Female | 36% | 9/25 |
| Indifferent | 0% | 0/25 |
| Unknown | 28% | 7/25 |
| General | ||
| Birth Length | 0% | 0/25 |
| 8% | 2/25 | |
| 4% | 1/25 | |
| 24% | 6/25 | |
| 16% | 4/25 | |
| 48% | 12/25 | |
| 56% | 14/25 | |
| 96% | 24/25 | |
| 96% | 24/25 | |
| 95.8% | 23/24 | |
| Neurology | ||
| 96% | 24/25 | |
| 56% | 14/25 | |
| 84% | 21/25 | |
| Facial abnormalities | ||
| 8% | 2/25 | |
| 28% | 7/25 | |
| 16% | 4/25 | |
| 28% | 7/25 | |
| Visual and hearing impairments | ||
| Abnormal hearing | 0% | 0/25 |
| 4% | 1/25 | |
| Heart | ||
| Abnormality of the heart | 0% | 0/25 |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/25 |
| Gastrointestinal | ||
| 28% | 7/25 | |
| Urogenital | ||
| Urogenital | 0% | 0/25 |
| Skeleton | ||
| 4% | 1/25 | |
| Skin / Hair / Nails | ||
| 20% | 5/25 | |
| Endocrine / Immunological / Metabolic | ||
| 8% | 2/25 | |
| 20% | 5/25 | |
| 20% | 5/25 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/25 |
| Inheritance | ||
| 92% | 23/25 | |
RHOBTB2